Pre- and post-term growth in pre-term infants supplemented with higher-dose DHA: A randomised controlled trial

Carmel T. Collins, Maria Makrides, Robert A. Gibson, Andrew J. McPhee, Peter G. Davis, Lex W. Doyle, Karen Simmer, Paul B. Colditz, Scott Morris, Thomas R. Sullivan, Philip Ryan

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The effect of the dietary n-3 long-chain PUFA, DHA (22:6n-3), on the growth of pre-term infants is controversial. We tested the effect of higher-dose DHA (approximately 1% dietary fatty acids) on the growth of pre-term infants to 18 months corrected age compared with standard feeding practice (0•20•3 % DHA) in a randomised controlled trial. Infants born < 33 weeks gestation (n 657) were randomly allocated to receive breast milk and/or formula with higher DHA or standard DHA according to a concealed schedule stratified for sex and birth-weight ( < 1250 and 1250 g). The dietary arachidonic acid content of both diets was constant at approximately 0•4 % total fatty acids. The intervention was from day 2 to 5 of life until the infant's expected date of delivery (EDD). Growth was assessed at EDD, and at 4, 12 and 18 months corrected age. There was no effect of higher DHA on weight or head circumference at any age, but infants fed higher DHA were 0•7 cm (95 % CI 0•1, 1•4 cm; P = 0•02) longer at 18 months corrected age. There was an interaction effect between treatment and birth weight strata for weight (P = 0•01) and length (P = 0•04). Higher DHA resulted in increased length in infants born weighing 1250 g at 4 months corrected age and in both weight and length at 12 and 18 months corrected age. Our data show that DHA up to 1 % total dietary fatty acids does not adversely affect growth.

LanguageEnglish
Pages1635-1643
Number of pages9
JournalBritish Journal of Nutrition
Volume105
Issue number11
DOIs
Publication statusPublished - 14 Jun 2011

Keywords

  • Fatty acids
  • Growth
  • Infants
  • Prematurity

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

@article{54ce1b9de8b9464fa8219dc730c0117c,
title = "Pre- and post-term growth in pre-term infants supplemented with higher-dose DHA: A randomised controlled trial",
abstract = "The effect of the dietary n-3 long-chain PUFA, DHA (22:6n-3), on the growth of pre-term infants is controversial. We tested the effect of higher-dose DHA (approximately 1{\%} dietary fatty acids) on the growth of pre-term infants to 18 months corrected age compared with standard feeding practice (0•20•3 {\%} DHA) in a randomised controlled trial. Infants born < 33 weeks gestation (n 657) were randomly allocated to receive breast milk and/or formula with higher DHA or standard DHA according to a concealed schedule stratified for sex and birth-weight ( < 1250 and 1250 g). The dietary arachidonic acid content of both diets was constant at approximately 0•4 {\%} total fatty acids. The intervention was from day 2 to 5 of life until the infant's expected date of delivery (EDD). Growth was assessed at EDD, and at 4, 12 and 18 months corrected age. There was no effect of higher DHA on weight or head circumference at any age, but infants fed higher DHA were 0•7 cm (95 {\%} CI 0•1, 1•4 cm; P = 0•02) longer at 18 months corrected age. There was an interaction effect between treatment and birth weight strata for weight (P = 0•01) and length (P = 0•04). Higher DHA resulted in increased length in infants born weighing 1250 g at 4 months corrected age and in both weight and length at 12 and 18 months corrected age. Our data show that DHA up to 1 {\%} total dietary fatty acids does not adversely affect growth.",
keywords = "Fatty acids, Growth, Infants, Prematurity",
author = "Collins, {Carmel T.} and Maria Makrides and Gibson, {Robert A.} and McPhee, {Andrew J.} and Davis, {Peter G.} and Doyle, {Lex W.} and Karen Simmer and Colditz, {Paul B.} and Scott Morris and Sullivan, {Thomas R.} and Philip Ryan",
year = "2011",
month = "6",
day = "14",
doi = "10.1017/S000711451000509X",
language = "English",
volume = "105",
pages = "1635--1643",
journal = "British Journal of Nutrition",
issn = "0007-1145",
publisher = "Cambridge University Press",
number = "11",

}

Pre- and post-term growth in pre-term infants supplemented with higher-dose DHA : A randomised controlled trial. / Collins, Carmel T.; Makrides, Maria; Gibson, Robert A.; McPhee, Andrew J.; Davis, Peter G.; Doyle, Lex W.; Simmer, Karen; Colditz, Paul B.; Morris, Scott; Sullivan, Thomas R.; Ryan, Philip.

In: British Journal of Nutrition, Vol. 105, No. 11, 14.06.2011, p. 1635-1643.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pre- and post-term growth in pre-term infants supplemented with higher-dose DHA

T2 - British Journal of Nutrition

AU - Collins, Carmel T.

AU - Makrides, Maria

AU - Gibson, Robert A.

AU - McPhee, Andrew J.

AU - Davis, Peter G.

AU - Doyle, Lex W.

AU - Simmer, Karen

AU - Colditz, Paul B.

AU - Morris, Scott

AU - Sullivan, Thomas R.

AU - Ryan, Philip

PY - 2011/6/14

Y1 - 2011/6/14

N2 - The effect of the dietary n-3 long-chain PUFA, DHA (22:6n-3), on the growth of pre-term infants is controversial. We tested the effect of higher-dose DHA (approximately 1% dietary fatty acids) on the growth of pre-term infants to 18 months corrected age compared with standard feeding practice (0•20•3 % DHA) in a randomised controlled trial. Infants born < 33 weeks gestation (n 657) were randomly allocated to receive breast milk and/or formula with higher DHA or standard DHA according to a concealed schedule stratified for sex and birth-weight ( < 1250 and 1250 g). The dietary arachidonic acid content of both diets was constant at approximately 0•4 % total fatty acids. The intervention was from day 2 to 5 of life until the infant's expected date of delivery (EDD). Growth was assessed at EDD, and at 4, 12 and 18 months corrected age. There was no effect of higher DHA on weight or head circumference at any age, but infants fed higher DHA were 0•7 cm (95 % CI 0•1, 1•4 cm; P = 0•02) longer at 18 months corrected age. There was an interaction effect between treatment and birth weight strata for weight (P = 0•01) and length (P = 0•04). Higher DHA resulted in increased length in infants born weighing 1250 g at 4 months corrected age and in both weight and length at 12 and 18 months corrected age. Our data show that DHA up to 1 % total dietary fatty acids does not adversely affect growth.

AB - The effect of the dietary n-3 long-chain PUFA, DHA (22:6n-3), on the growth of pre-term infants is controversial. We tested the effect of higher-dose DHA (approximately 1% dietary fatty acids) on the growth of pre-term infants to 18 months corrected age compared with standard feeding practice (0•20•3 % DHA) in a randomised controlled trial. Infants born < 33 weeks gestation (n 657) were randomly allocated to receive breast milk and/or formula with higher DHA or standard DHA according to a concealed schedule stratified for sex and birth-weight ( < 1250 and 1250 g). The dietary arachidonic acid content of both diets was constant at approximately 0•4 % total fatty acids. The intervention was from day 2 to 5 of life until the infant's expected date of delivery (EDD). Growth was assessed at EDD, and at 4, 12 and 18 months corrected age. There was no effect of higher DHA on weight or head circumference at any age, but infants fed higher DHA were 0•7 cm (95 % CI 0•1, 1•4 cm; P = 0•02) longer at 18 months corrected age. There was an interaction effect between treatment and birth weight strata for weight (P = 0•01) and length (P = 0•04). Higher DHA resulted in increased length in infants born weighing 1250 g at 4 months corrected age and in both weight and length at 12 and 18 months corrected age. Our data show that DHA up to 1 % total dietary fatty acids does not adversely affect growth.

KW - Fatty acids

KW - Growth

KW - Infants

KW - Prematurity

UR - http://www.scopus.com/inward/record.url?scp=79958701508&partnerID=8YFLogxK

U2 - 10.1017/S000711451000509X

DO - 10.1017/S000711451000509X

M3 - Article

VL - 105

SP - 1635

EP - 1643

JO - British Journal of Nutrition

JF - British Journal of Nutrition

SN - 0007-1145

IS - 11

ER -